The influence of dermatologist and primary care physician visits on melanoma outcomes among medicare beneficiaries

Journal of the American Board of Family Medicine

Volumn 26, Issue 6, 2013, Pages 637-647

  Roetzheim, Richard G ^a,b   Lee, Ji Hyun ^b   Ferrante, Jeanne M ^b,c,d   Gonzalez, Eduardo C ^a   Chen, Ren ^a   Fisher, Kate J ^b   Love Jackson, Kymia ^a   McCarthy, Ellen P ^e  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dermatology; Medicare; Melanoma; Primary care physicians; SEER program

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DERMATOLOGIST; FEMALE; GENERAL PRACTITIONER; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT;

DERMATOLOGY; MEDICARE; MELANOMA; PRIMARY CARE PHYSICIANS; SEER PROGRAM;

AGED; AGED, 80 AND OVER; DERMATOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE; MELANOMA; OFFICE VISITS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84888366924     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2013.06.130042     Document Type: Article

References (55)

1. Siegel R, Ward E, Brawley O., Jemal A. Cancer statistics, 2011: the impact of eliminating socioeco-nomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212-36.
2. Markovic SN, Erickson LA, Rao R.D., et al Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007; 82: 490-513. (Pubitemid 46543475)
3. Epstein D, Lange J, Gruber S., Mofid M, Koch S. Is physician detection associated with thinner melanomas? JAMA 1999; 281:640-3. (Pubitemid 29098065)
4. Kantor J, Kantor DE Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol 2009; 145:873-6.
5. Kovalyshyn I, Dusza SW, Siamas K, Halpern A.C., Argenziano G., Marghoob AA The impact of physician screening on melanoma detection. Arch Derma-tol 2011; 147:1269-75.
6. McGuire ST, Secrest AM, Andrulonis R, Ferris LK Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery. Arch Dermatol 2011; 147:673-8.
7. Fisher NM, Schaffer JV, Berwick M, Bolognia JL Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 2005; 53:393-406. (Pubitemid 41195959)
8. Durbec F, Vitry F, Granel-Brocard F, et al The role of circumstances of diagnosis and access to derma-tological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010; 146:240-6.
9. Eide MJ, Weinstock MA, Clark MA The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993. J Am Acad Dermatol 2009; 60:51-8.
10. Roetzheim R, Pal N, Van Durme D, et al Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Derm 2000; 43:211-8. (Pubitemid 30625995)
11. U.S. Preventive Services Task Force. Screening for skin cancer. February 2009. Available from: http://www.uspreventiveservicestaskforce.org/uspstf/ uspsskca. htm. Accessed September 12, 2013.
12. Whitcomb ME, Cohen JJ The future of primary care medicine. N Engl J Med 2004; 351:710-2. (Pubitemid 39063275)
13. Kimball AB, Resneck JS Jr. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol 2008; 59:741-5.
14. Uhlenhake E, Brodell R, Mostow E. The dermatology work force: a focus on urban versus rural wait times. J Am Acad Dermatol 2009; 61:17-22.
15. Tsang MW, Resneck JS Jr. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol 2006; 55:54-8. (Pubitemid 43867047)
16. Alam M, Goldberg LH, Silapunt S, et al Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011; 64:839-48.
17. Ries LAG, Young JL, Keel G.E., Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988-2001, patient and tumor characteristics. NIH pub. no. 07-6215. Bethesda, MD: National Cancer Institute; 2007. Available from: http://seer.cancer. gov/publications/survival/. Accessed September 12, 2013.
18. Brull R, Ghali WA, Quan H. Missed opportunities for prevention in general internal medicine. CMAJ 1999; 160:1137-40. (Pubitemid 29206315)
19. Freeman HJ. Documentation of rectal examination performance in the clinical teaching unit of a university hospital. Can J Gastroenterol 2000; 14:272-6. (Pubitemid 30265370)
20. Harrison RV, Janz NK, Wolfe R.A., Tedeschi PJ, Huang X, McMahon LF Jr. 5-Year mammography rates and associated factors for older women. Cancer. 2003; 97:1147-55. (Pubitemid 36237298)
21. Huth JF, O'Connor AP. Breast cancer screening practices for hospitalized women. J Cancer Educ 1995; 10:22-4.
22. Sharma VK, Komanduri S, Nayyar S., et al An audit of the utility of in-patient fecal occult blood testing. Am J Gastroenterol 2001; 96:1256-60. (Pubitemid 32319170)
23. Trimble CL, Richards LA, Wilgus-Wegweiser B, Plowden K., Rosenthal DL, Klassen A. Effectiveness of screening for cervical cancer in an inpatient hospital setting. Obstet Gynecol 2004; 103:310-6.
24. Van Harrison R., Janz NK, Wolfe R.A., et al Characteristics of primary care physicians and their practices associated with mammography rates for older women. Cancer 2003; 98:1811-21. (Pubitemid 37310222)
25. White MJ. Consideration of women's health issues by housestaff performing admitting histories and physical examinations. Acad Med 1993; 68:698-700. (Pubitemid 23308152)
26. Ziffer A, Song P, Mandelblatt J. Preventive health practices in a teaching hospital: house staff attitudes and performance of gynecological screening. Am J Prev Med 1987; 3:142-6. (Pubitemid 17118099)
27. Yu X, McBean AM, Virnig BA Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv 2007; 1:275-82.
28. Baldwin LM, Adamache W, Klabunde C.N., Kenward K., Dahlman C, Warren JL Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care 2002; 40(8 Suppl):82-95.
29. Valderas JM, Starfield B, Forrest C.B., Sibbald B., Roland M. Ambulatory care provided by office-based specialists in the United States. Ann Fam Med 2009; 7:104-11.
30. Criscione VD, Weinstock MA Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol 2010; 130:793-7.
31. Demierre MF, Chung C, Miller D.R., Geller AC Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol 2005; 141:745-50. (Pubitemid 41001075)
32. Gimotty PA, Botbyl J, Soong S.J., Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2005; 23:8065-75. (Pubitemid 46657409)
33. Charlson M, Pompei P, Ales K., Mackenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-83. (Pubitemid 17055592)
34. Klabunde CN, Potosky AL, Legler J.M., Warren JL Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53:1258-67. (Pubitemid 32007842)
35. Brookhart MA, Patrick AR, Dormuth C, et al Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007; 166:348-54. (Pubitemid 47216808)
36. Ferrante JM, McCarthy EP, Gonzalez E.C., et al Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med 2011; 171:1747-57.
37. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993; 80:557-72.
38. Geller AC, Johnson TM, Miller D.R., Brooks KR, Layton CJ, Swetter SM Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009; 145:409-14.
39. Di Quinzio M.L., Dewar RA, Burge F.I., Veugelers PJ Family physician visits and early recognition of melanoma. Can J Public Health 2005; 96:136-9. (Pubitemid 40528715)
40. Chen SC, Pennie ML, Kolm P, et al Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006; 21:678-82. (Pubitemid 43973549)
41. Pennie ML, Soon SL, Risser J.B., Veledar E., Culler SD, Chen SC Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007; 143:488-94. (Pubitemid 46631647)
42. Bordeaux JS, Lu KQ, Cooper KD Melanoma: prevention and early detection. Semin Oncol 2007; 34: 460-6. (Pubitemid 350236311)
43. Goulart JM, Quigley EA, Dusza S, et al Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 2011; 26:1027-35.
44. Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 150: 194-8.
45. Welch HG, Woloshin S, Schwartz LM Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005; 331:481.
46. Welch HG, Black WC Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102:605-13.
47. Jemal A, Saraiya M, Patel P., et al Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol 2011; 65(5 Suppl 1):S17-25.e1-3.
48. McLaughlin JM, Fisher JL, Paskett ED Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006. Cancer 2011; 117:1984-93.
49. Reyes Ortiz C.A., Freeman JL, Kuo Y.F., Goodwin JS The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci 2007; 62:892-8. (Pubitemid 350131675)
50. Baumert J, Plewig G, Volkenandt M., Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007; 156:938-44. (Pubitemid 46642845)
51. Mandala M, Imberti GL, Piazzalunga D, et al Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma. Mayo Clin Proc 2011; 86:113-9.
52. Swetter SM, Johnson TM, Miller D.R., Layton CJ, Brooks KR, Geller AC Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 2009; 145:397-404.
53. Ward EM, Fedewa SA, Cokkinides V, Virgo K. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J 2010; 16:614-21.
54. Roetzheim RG, Pal N, Tennant C., et al Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91:1409-15. (Pubitemid 29400000)
55. Watson M, Johnson CJ, Chen V.W., et al Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol 2011; 65:S6-16.